News

Main changes in the amended version of the Horizon Europe Cluster 5 work programme & new Mission Calls

Published on | 1 year ago

Programmes Climate, Energy, Mobility Missions

The European Commission has published the amendments to the Horizon Europe main workprogramme.

The main changes for Cluster 5 - Climate, Energy & Mobility concern:

  • Two new call topics have been included in the amended Cluster 5 Work Programme:
    • HORIZON-CL5-2024-D3-02-13: Support to the activities of the SET Plan Key Action area Renewable fuels and bioenergy
    • HORIZON-CL5-2024-D6-01-13: EU Member States/Associated countries research policy cooperation network to accelerate zero-emission road mobility (2ZERO Partnership)

  • Changes have been made to the topic texts / topic conditions for the following call topics: HORIZON-CL5-2024-D2-02-02; HORIZON-CL5-2024-D3-02-01; HORIZON-CL5-2024-D3-02-06; HORIZON-CL5-2024-D3-02-12; HORIZON-CL5-2024-D4-02-02; HORIZON-CL5-2024-D4-02-04; HORIZON-CL5-2024-D6-01-05; HORIZON-CL5-2024-D6-01-01; HORIZON-CL5-2024-D6-01-09

  • Following topics have an increase of budget: HORIZON-CL5-2024-D2-01-04; HORIZON-CL5-2024-D6-01-05


The European Commission will soon publish a document with a detailed overview of the updates ('History of updates') on the Funding and Tenders Portal under 'Reference documents'. 


As part of the amendment, 5 new Cities Mission call for proposals (2024) and 9 new Climate Adaptation Mission calls for proposals (2024) were published under the Missions work programme .

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1649 articles available search in articles 

Testimonial

image of Methylomic โ€“ Hope & Improved outcomes for Crohnโ€™s disease patients across Europe

Methylomic โ€“ Hope & Improved outcomes for Crohnโ€™s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.